- Open Access
Innate recognition of non-self nucleic acids
© BioMed Central Ltd 2008
- Published: 10 March 2008
The immune system has evolved a plethora of innate receptors that detect microbial DNA and RNA, including Toll-like receptors in the endosomal compartment and RIG-I-like receptors and Nod-like receptors in the cytosol. Here we discuss the recognition of and responses to non-self nucleic acids via these receptors as well as their involvement in autoimmune diseases.
- West Nile Virus
- Endosomal Compartment
- Interferon Response
- Japanese Encephalitis Virus
- Innate Immune Receptor
Major pattern recognition receptors involved in the recognition of non-self nucleic acids
Toll-like receptors (TLRs)
CpG DNA, abnormal DNA
RIG-I-like receptors (RLRs)
Nod-like receptors (NLRs)
Bacterial and viral RNA
TLR9 was the first TLR identified to interact with nucleic acids, and its classical ligand is CpG DNA, an immuno-stimulatory DNA composed of unmethylated CpG dinucleo-tides with particular flanking sequences . The CpG motif is abundant in bacterial genomes as well as in the DNA of viruses such as herpes simplex virus 1 (HSV-1), HSV-2 and murine cytomegalovirus (MCMV), allowing these pathogens to be recognized by TLR9. In contrast, in mammalian genomes the CpG motif occurs much less frequently and is highly methylated, which does not activate innate immunity. CpG DNA induces a conformational change in TLR9 that is required for its activation . In addition to CpG DNA, recent findings indicate that oligodeoxyribonucleotides containing no CpG motifs but with a phosphorothioate backbone, or modified nucleotides with a bicyclic heterobase can activate the innate immune system in a TLR9-dependent manner. Therefore, TLR9 might have evolved to recognize not only unmethylated CpG motifs as a conserved molecular pattern in pathogen DNA but also abnormal composition, structure or chemical features in any kind of DNA .
TLR9 is highly expressed in dendritic cells, the 'professional' antigen-presenting cells that link innate and adaptive immune responses, and in other immune system cells such as B cells. TLR9 expression patterns are different in humans and mice. In mice, TLR9 is expressed broadly in the different subsets of dendritic cells, whereas in humans it is exclusively expressed by plasmacytoid dendritic cells (pDCs), a subtype characterized by the ability to secrete high levels of type I interferons in response to viral infection. In pDCs, TLR9 acts as a sensor of viral infection, which leads to the transcription of type I interferons, particularly interferon-α, through the MyD88-interferon response factor 7 (IRF7) signaling pathway. In other cells, such as conventional dendritic cells (cDCs) and macrophages, TLR9 ligands are poor at inducing type I interferons but they can induce inflammatory cytokines through the MyD88-IRF1 pathway . TLR9-deficient mice show increased susceptibility to MCMV infection but not to local infection by HSV-1 [9–11], indicating a specific role for TLR9 in viral sensing and antiviral responses.
Double-stranded RNA (dsRNA), along with its synthetic analog polyinosinedeoxycytidylic acid (poly I:C) is a potent inducer of the type I interferons and is recognized by TLR3 . Double-stranded RNA can be generated during viral infection as a replication intermediate for single-stranded RNA (ssRNA) viruses or as a byproduct of symmetrical transcription in DNA viruses. TLR3 is expressed in cDCs, which avidly phagocytose dying cells, and in a variety of epithelial cells, including airway, uterine and intestinal epithelial cells that function as efficient barriers to infection. Expression of TLR3 in these cells is also rapidly induced by treatment with poly I:C or type I interferons. TLR3 signals exclusively through the TLR adaptor TRIF, leading to the IRF3-dependent induction of type I interferons. As dsRNA is a universal viral product, TLR3 was originally thought to play a key role in antiviral immunity. However, the induction of type I interferons and the maturation of dendritic cells after viral infection occur in a TLR3-independent manner , and TLR3-deficient mice respond normally to infection with many viruses, including MCMV, vesicular stomatitis virus (VSV), lymphocytic choriomeningitis virus (LCMV) and reovirus [14–16]. Indeed, TLR3-deficient mice are more resistant than normal to lethal West Nile virus infection. In this infection, a strong inflammatory response mediated by TLR3 in peripheral tissues results in the disruption of the blood-brain barrier, facilitating entry of the virus into the brain, suggesting that the interaction of TLR3 with West Nile virus actually facilitates the infection . A role for TLR3 in exacerbating immunopathology has also been found in infection with influenza virus and Punta Toro virus [18, 19]. In vivo, therefore, TLR3 plays an important role in evoking inflammatory responses in response to RNA virus infection - a response that can be detrimental to the host - rather than in the production of type I interferons. In addition to detecting viral dsRNA, TLR3 can also be activated by dsRNA from the helminth parasite Schistosoma in dendritic cells .
The TLR7 and TLR8 genes are very similar in sequence to each other and are both located on the X chromosome. Mouse TLR7 and human TLR8 recognize synthetic antiviral imidazoquinolines (such as R848 and Imiquimod), certain guanine nucleotide analogs (for example, loxoribine), and uridine-rich or uridine/guanosine-rich ssRNA of both viral and host origin [21–23]. Although both TLR7 and TLR8 are expressed in mice, mouse TLR8 appears to be nonfunctional. TLR7 and TLR8 are present in the endosomal membranes of pDCs, indicating that access to ssRNA may be a key factor for activation of these cells via these receptors. Like TLR9, TLR7 and TLR8 signal exclusively through MyD88 to induce an interferon response. TLR7-deficient pDCs are defective in interferon-α production after stimulation with influenza virus , and TLR7-deficient mice show increased sensitivity to VSV , indicating a role for TLR7 in antiviral defense in vivo.
RIG-I and melanoma differentiation-associated gene 5 (MDA5)/Helicard are DExD/H box RNA helicases that have recently been implicated in the regulation of interferon gene expression following sensing of viral RNA in the cytosol. Both of these proteins contain caspase recruitment and activation domains (CARDs) and detect RNA viruses and synthetic poly I:C [27–29]. The critical determinant in RIG-I stimulation by RNA is the presence of triphosphates at the 5' end of ssRNA [30, 31]. Host 5'-triphosphate ssRNA exist in the nucleus but not the cytoplasm; host ssRNA in the cytoplasm are normally capped or processed. The agonist for MDA5 remains uncharacterized, although MDA5 is known to respond to dsRNA. A third member of the RLR family, the protein LGP2, shares homology with RIG-I and MDA5 in the helicase domain and can bind dsRNA. However, LGP2 lacks a CARD domain and has been proposed to act as a negative regulator of RIG-I or MDA5 signaling [32, 33].
Upon RNA recognition, RIG-I and MDA5 signal through the adaptor molecule interferon-β promoter stimulator 1 (IPS-1, also known as MAVS, Cardif and VISA) to downstream signaling proteins that include the adaptor Fas-associated death domain-containing protein (FADD), and the death-domain-containing kinase RIP1, TANK-binding kinase 1 (TBK1) and the inducible I-kappaB kinase (IKK-i), leading to transcription of the interferon genes [2, 34]. Experiments with mice deficient in RIG-I or MDA5 indicate that the two helicases are critical for host antiviral responses and distinguish different viruses [35, 36]. RIG-I is essential for the production of interferon in response to RNA viruses such as paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, compared with control mice, RIG-I-/- and MDA5-/- mice are highly susceptible to infection with the respective RNA viruses [35, 36].
A pathway analogous to that stimulated by RIG-I and MDA5 has been suggested to signal an innate immune response to DNA in the cytosol. HSV-1 elicits type I interferon production via both TLR9-independent and -dependent pathways . Similarly, cytosolic DNA has been shown to be an interferon-activating ligand independent of TLRs in intracellular infection with the bacterium Listeria monocytogenes . Cytosolic DNA sensing does not require RIG-I or MDA5 , suggesting the involvement of a new factor. The first cytosolic DNA sensor identified was the interferon-inducible protein DAI, which can activate IRF3 and induce an interferon response in cells . Binding of dsDNA to DAI enhances the protein's association with the transcription factor IRF3 and the kinase TBK1. Over-expression of DAI in mouse fibroblasts selectively enhances DNA-mediated induction of type I interferons and of other genes involved in innate immunity. Thus, DAI may be central to detection of the DNA of viruses, bacteria, fungi and parasites that enter host cells. Generation and analysis of mice deficient in DAI should define its function more clearly. Inhibition of DAI synthesis by small interfering RNAs reduced interferon production after DNA stimulation but did not abolish it , suggesting that additional cytosolic DNA sensors might exist.
A common feature of the recognition of non-self nucleic acids by TLRs, RLRs and DAI is their ability to induce robust activation of genes for interferons and/or pro-inflammatory cytokines, which endow these receptors with a central role in innate immunity. Various other mechanisms that recognize non-self nucleic acids do not result in gene activation. One important post-transcriptional pathway for the regulation of innate immunity is mediated by the intracellular NLRs [41, 42]. These cytosolic pattern recognition receptors induce the activation of the protease caspase-1 through the assembly of large protein complexes called inflammasomes. One of the NLRs, cryopyrin/Nalp3, mediates caspase-1 activation and the processing and secretion of the cytokines interleukin 1β (IL-1β) and IL-18 in response to bacterial and viral RNA, poly I:C and the imidazoquinolines R837 and R848 as well as to viral infection . Whether cryopyrin/Nalp3 directly recognizes RNA and imidazo-quinoline is unclear, because no direct association has been reported. NLRX1, a mitochondrially localized NLR, plays a negative role in antiviral immunity by antagonizing the interaction between RIG-I and IPS-1, suggesting that NLRX1 functions as a modulator of the responses to pathogen components rather than as a receptor that regulates antiviral innate immunity .
Several enzymes whose activities depend on the presence of dsRNA are also involved in innate immunity. One mechanism involves two enzymes, protein kinase R (PKR) and general control nonderepressible-2 (GCN-2), which phosphorylate the α subunit of translation initiation factor 2, leading to the downregulation of protein translation, and therefore of virus replication, within infected cells . In PKR-deficient mice, antiviral responses are reduced when dsRNA or interferon are given along with the virus as coactivators. However, PKR deficiency does not affect the induction of type I interferons by dsRNA and viruses, suggesting that PKR is acting as an effector of interferon action rather than in the induction of interferon synthesis. Another protein that is stimulated by dsRNA is 2'-5' oligo-adenylate synthetase, an enzyme that synthesizes short oligoadenylates that in turn activate the endoribonuclease RNase L. Upon activation, RNase L promotes the cleavage of both cellular and viral RNAs. As with PKR, the analysis of RNase L-deficient mice revealed the requirement for this enzyme in interferon-dependent antiviral actions . Although PKR and RNase L become activated by dsRNA and are implicated in antiviral immunity, they are mainly effectors of interferon action and are dispensable for interferon production, and generally are not defined as pattern recognition receptors.
Although all the defense mechanisms described above are designed for the recognition of microbial nucleic acids, they can in some circumstances lead to the recognition of host DNA and RNA and the development of autoimmunity . TLRs specific for nucleic acids are normally localized to the endosomal compartment, which may be the safeguard against contact with self DNA . Unfortunately for the host, endogenous RNA and DNA are also able to activate TLR7 and TLR9 if they enter the endosomal compartment. A rich potential source of self RNA and DNA are the remains of host cells that have died via necrosis or apoptosis. Normally such apoptotic debris appears to be cleared rapidly by macrophages, which in humans do not express TLR7 or TLR9. But if there is a delay in apoptotic clearance, or if there are autoantibodies that interact with the antigens exposed on the apoptotic cells, this material can be misdirected to pDCs and B cells, where the nucleic acids can activate TLR7 and/or TLR9, resulting in the secretion of type I interferons by pDCs and the differentiation of B cells into plasma cells. Such a mechanism is likely to be the cause of pDC secretion of type I interferons in systemic lupus erythematosus (SLE) patients, in which increased serum concentrations of interferon-α correlate with disease activity and probably contribute to disease pathogenesis. In the mouse model of SLE, the genetic locus Y chromosome-linked autoimmune accelerator (Yaa) acts as a disease accelerator, promoting SLE in genetically susceptible mouse strains. Recent genetic studies revealed that Yaa is a duplication and translocation of the TLR7 gene from the X chromosome onto the Y chromosome, increasing the dosage of the TLR7 gene in the cell [48, 49]. Further studies showed that the gene dosage of TLR7 is directly related to the risk of autoimmunity .
TLR-independent mechanisms for the recognition of self nucleic acids also contribute to autoimmunity. Deoxyribo-nuclease II (DNase II) in macrophages cleaves the DNA of engulfed apoptotic cells and of engulfed nuclei that have been expelled from erythroid precursor cells. In mice deficient in DNase II, genomic DNA cannot be degraded and accumulates in the macrophage phagosome, leading to TLR-independent, interferon-mediated autoimmune pathology . Whether DAI or other cytosolic DNA sensors contribute to such autoimmunity awaits further investigation.
The discovery of pattern recognition receptors has thus revolutionized our understanding of innate immunity, explaining why and how multiple and diverse infectious agents are recognized by a limited number of innate immune receptors that trigger antimicrobial responses . We are beginning to appreciate how a variety of such receptors at distinct cellular localizations recognize non-self nucleic acids derived from infectious microorganisms and initiate a proper immune response against them, while at the same time maintaining tolerance to self DNA and RNA to prevent development of autoimmunity. How such a delicate balance is established is not well understood and it probably involves both the receptors themselves and the way host nucleic acids are handled in the cell. For example, sequestration of certain TLRs in the endosomal compartments and packaging of mammalian DNA into high-order chromatin structure may both prevent the accidental activation of innate responses to self nucleic acids. It will also be important to dissect the molecular mechanisms and structural basis of the interactions of these receptors with their ligands, a task that should become easier following the recent elucidation of the structures of several TLRs [52–55]. Finally, the mechanisms underlying the sensing of cytosolic DNA by DAI and other possible factors have not yet been established and await further investigation. Eventually, research on innate recognition of non-self nucleic acids is likely to be translated into the development of new strategies for the prevention and therapy of infectious and autoimmune diseases.
We thank Fran Manzo for assistance with editing and Thirumala-Devi Kan-neganti for critical reading of the manuscript. HC acknowledges support from the Arthritis Foundation and NIH (K01AR053573). RAF is an investigator of the Howard Hughes Medical Institute.
- Janeway CA: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989, 54: 1-13.PubMedView ArticleGoogle Scholar
- Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.PubMedView ArticleGoogle Scholar
- Medzhitov R: Recognition of microorganisms and activation of the immune response. Nature. 2007, 449: 819-826. 10.1038/nature06246.PubMedView ArticleGoogle Scholar
- Kawai T, Akira S: TLR signaling. Semin Immunol. 2007, 19: 24-32. 10.1016/j.smim.2006.12.004.PubMedView ArticleGoogle Scholar
- Barton GM, Kagan JC, Medzhitov R: Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2006, 7: 49-56. 10.1038/ni1280.PubMedView ArticleGoogle Scholar
- Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature. 2000, 408: 740-745. 10.1038/35047123.PubMedView ArticleGoogle Scholar
- Latz E, Verma A, Visintin A, Gong M, Sirois CM, Klein DC, Monks BG, McKnight CJ, Lamphier MS, Duprex WP, Espevik T, Golenbock DT: Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol. 2007, 8: 772-779. 10.1038/ni1479.PubMedView ArticleGoogle Scholar
- Ishii KJ, Akira S: Innate immune recognition of, and regulation by, DNA. Trends Immunol. 2006, 27: 525-532. 10.1016/j.it.2006.09.002.PubMedView ArticleGoogle Scholar
- Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM, Colonna M: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 2004, 21: 107-119. 10.1016/j.immuni.2004.06.007.PubMedView ArticleGoogle Scholar
- Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, Alexopoulou L, Flavell RA, Beutler B: Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA. 2004, 101: 3516-3521. 10.1073/pnas.0400525101.PubMedPubMed CentralView ArticleGoogle Scholar
- Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M: Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood. 2004, 103: 1433-1437. 10.1182/blood-2003-08-2674.PubMedView ArticleGoogle Scholar
- Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001, 413: 732-738. 10.1038/35099560.PubMedView ArticleGoogle Scholar
- Lopez CB, Moltedo B, Alexopoulou L, Bonifaz L, Flavell RA, Moran TM: TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol. 2004, 173: 6882-6889.PubMedView ArticleGoogle Scholar
- Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB: Does Toll-like receptor 3 play a biological role in virus infections?. Virology. 2004, 322: 231-238. 10.1016/j.virol.2004.01.033.PubMedView ArticleGoogle Scholar
- Johansson C, Wetzel JD, He J, Mikacenic C, Dermody TS, Kelsall BL: Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J Exp Med. 2007, 204: 1349-1358. 10.1084/jem.20061587.PubMedPubMed CentralView ArticleGoogle Scholar
- Schroder M, Bowie AG: TLR3 in antiviral immunity: key player or bystander?. Trends Immunol. 2005, 26: 462-468. 10.1016/j.it.2005.07.002.PubMedView ArticleGoogle Scholar
- Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004, 10: 1366-1373. 10.1038/nm1140.PubMedView ArticleGoogle Scholar
- Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M: Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2006, 2: e53-10.1371/journal.ppat.0020053.PubMedView ArticleGoogle Scholar
- Gowen BB, Hoopes JD, Wong MH, Jung KH, Isakson KC, Alexopoulou L, Flavell RA, Sidwell RW: TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J Immunol. 2006, 177: 6301-6307.PubMedView ArticleGoogle Scholar
- Aksoy E, Zouain CS, Vanhoutte F, Fontaine J, Pavelka N, Thieblemont N, Willems F, Ricciardi-Castagnoli P, Goldman M, Capron M, Ryffel B, Trottein F: Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem. 2005, 280: 277-283.PubMedView ArticleGoogle Scholar
- Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004, 303: 1526-1529. 10.1126/science.1093620.PubMedView ArticleGoogle Scholar
- Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004, 303: 1529-1531. 10.1126/science.1093616.PubMedView ArticleGoogle Scholar
- Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA. 2004, 101: 5598-5603. 10.1073/pnas.0400937101.PubMedPubMed CentralView ArticleGoogle Scholar
- Rotem Z, Cox RA, Isaacs A: Inhibition of virus multiplication by foreign nucleic acid. Nature. 1963, 197: 564-566. 10.1038/197564a0.PubMedView ArticleGoogle Scholar
- Jensen KE, Neal AL, Owens RE, Warren J: Interferon responses of chick embryo fibroblasts to nucleic acids and related compounds. Nature. 1963, 200: 433-434. 10.1038/200433a0.PubMedView ArticleGoogle Scholar
- Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S: Cell type-specific involvement of RIG-I in antiviral response. Immunity. 2005, 23: 19-28. 10.1016/j.immuni.2005.04.010.PubMedView ArticleGoogle Scholar
- Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004, 5: 730-737. 10.1038/ni1087.PubMedView ArticleGoogle Scholar
- Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE: The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA. 2004, 101: 17264-17269. 10.1073/pnas.0407639101.PubMedPubMed CentralView ArticleGoogle Scholar
- Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB: mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA. 2002, 99: 637-642. 10.1073/pnas.022637199.PubMedPubMed CentralView ArticleGoogle Scholar
- Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G: 5'-Triphosphate RNA is the ligand for RIG-I. Science. 2006, 314: 994-997. 10.1126/science.1132505.PubMedView ArticleGoogle Scholar
- Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science. 2006, 314: 997-1001. 10.1126/science.1132998.PubMedView ArticleGoogle Scholar
- Rothenfusser S, Goutagny N, DiPerna G, Gong M, Monks BG, Schoenemeyer A, Yamamoto M, Akira S, Fitzgerald KA: The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol. 2005, 175: 5260-5268.PubMedView ArticleGoogle Scholar
- Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M, Akira S, Yonehara S, Kato A, Fujita T: Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005, 175: 2851-2858.PubMedView ArticleGoogle Scholar
- Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005, 6: 981-988. 10.1038/ni1243.PubMedView ArticleGoogle Scholar
- Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006, 441: 101-105. 10.1038/nature04734.PubMedView ArticleGoogle Scholar
- Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M: Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA. 2006, 103: 8459-8464. 10.1073/pnas.0603082103.PubMedPubMed CentralView ArticleGoogle Scholar
- Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA. 2004, 101: 11416-11421. 10.1073/pnas.0403555101.PubMedPubMed CentralView ArticleGoogle Scholar
- Stetson DB, Medzhitov R: Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006, 24: 93-103. 10.1016/j.immuni.2005.12.003.PubMedView ArticleGoogle Scholar
- Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S: A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol. 2006, 7: 40-48. 10.1038/ni1282.PubMedView ArticleGoogle Scholar
- Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T: DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007, 448: 501-505. 10.1038/nature06013.PubMedView ArticleGoogle Scholar
- Kanneganti TD, Lamkanfi M, Nunez G: Intracellular NOD-like receptors in host defense and disease. Immunity. 2007, 27: 549-559. 10.1016/j.immuni.2007.10.002.PubMedView ArticleGoogle Scholar
- Ogura Y, Sutterwala FS, Flavell RA: The inflammasome: first line of the immune response to cell stress. Cell. 2006, 126: 659-662. 10.1016/j.cell.2006.08.002.PubMedView ArticleGoogle Scholar
- Kanneganti TD, Ozören N, Body-Malapel M, Amer A, Park JH, Franchi L, Whitfield J, Barchet W, Colonna M, Vandenabeele P, Bertin J, Coyle A, Grant EP, Akira S, Núñez G: Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006, 440: 233-236. 10.1038/nature04517.PubMedView ArticleGoogle Scholar
- Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD, Heise MT, Chen Z, Ting JP: NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008, 451: 573-577. 10.1038/nature06501.PubMedView ArticleGoogle Scholar
- Williams BR: Signal integration via PKR. Sci STKE. 2001, 2001: RE2-PubMedGoogle Scholar
- Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH: Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J. 1997, 16: 6355-6363. 10.1093/emboj/16.21.6355.PubMedPubMed CentralView ArticleGoogle Scholar
- Krieg AM, Vollmer J: Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007, 220: 251-269. 10.1111/j.1600-065X.2007.00572.x.PubMedView ArticleGoogle Scholar
- Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006, 312: 1669-1672. 10.1126/science.1124978.PubMedView ArticleGoogle Scholar
- Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, Liang C, Bartov G, McDaniel LD, Zhou XJ, Schultz RA, Wakeland EK: A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA. 2006, 103: 9970-9975. 10.1073/pnas.0603912103.PubMedPubMed CentralView ArticleGoogle Scholar
- Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S: Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 2007, 27: 801-810. 10.1016/j.immuni.2007.09.009.PubMedPubMed CentralView ArticleGoogle Scholar
- Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S: Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med. 2005, 202: 1333-1339. 10.1084/jem.20051654.PubMedPubMed CentralView ArticleGoogle Scholar
- Bell JK, Askins J, Hall PR, Davies DR, Segal DM: The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci USA. 2006, 103: 8792-8797. 10.1073/pnas.0603245103.PubMedPubMed CentralView ArticleGoogle Scholar
- Choe J, Kelker MS, Wilson IA: Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science. 2005, 309: 581-585. 10.1126/science.1115253.PubMedView ArticleGoogle Scholar
- Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO: Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007, 130: 906-917. 10.1016/j.cell.2007.08.002.PubMedView ArticleGoogle Scholar
- Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO: Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007, 130: 1071-1082. 10.1016/j.cell.2007.09.008.PubMedView ArticleGoogle Scholar